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Islet cell tumors of the pancreas are a rare entity among
pancreatic tumors. Among them, insulinoma is the
most common type. Because insulinomas can often
be cured by surgical resection, it is important to pre-
cisely locate the tumor prior to surgery. However, due
to their small size at the time of presentation, it is often
difficult to locate their exact position. This article
presents the case of a female who was diagnosed with
insulinoma associated with hypoglycemia unaware-
ness and transient impairment of the hypothalamus–
pituitary–adrenal (HPA) axis.
CASE PRESENTATION
A 24 year-old female was found unconscious and
brought to our hospital. On physical examination,
her blood pressure was 126/68 mmHg, heart rate
was 104 beats per minute, and body temperature was
36.7°C. Laboratory tests were in the normal range
(Table 1) except for plasma glucose level (16 mg/dL).
After receiving glucose water infusion, she recovered
consciousness.
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Insulinoma is the most common functional tumor among pancreatic islet cell tumors. This type
of tumor is difficult to localize prior to surgery and can lead to serious hypoglycemia. This paper
presents the case of a young female who suffered from insulinoma associated with transient
hypothalamus–pituitary–adrenal axis impairment. To localize her insulinoma, we used two alter-
native testing methods, somatostatin receptor scintigraphy and selective arterial calcium stimu-
lation with venous sampling, after a failure of conventional imaging methods. We treated her
adrenal insufficiency and prevented serious hypoglycemia by giving her prednisolone. The
impairment in her hypothalamus–pituitary–adrenal axis and her serious hypoglycemia recov-
ered after excision of the tumor.
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After admission, the patient experienced several
hypoglycemic attacks, but complained of no discom-
fort. A fasting test was arranged, but was terminated
shortly thereafter because of her serious hypoglycemia.
At the time of hypoglycemia, laboratory data were as
follows: plasma glucose, 37 mg/dL (normal range, 70–
100 mg/dL); C-peptide, 5.0 ng/mL (normal range,
0.5–2ng/mL); insulin, 15.3µIU/mL (normal range, 8.3–
22 µIU/mL); cortisol, 5.3 µg/dL (normal range, AM
5–25 µg/dL, PM ≤ 1/2 AM value). This laboratory
data indicated two possibilities: insulinoma or adrenal
insufficiency.
Suspecting insulinoma-associated hypoglycemia,
we arranged abdominal ultrasonography, abdominal
magnetic resonance imaging and angiography with
the intention of localizing the tumor. However, these
methods failed to locate the tumor. There was an
approximately 20-day outpatient period before the
next examination. We arranged somatostatin receptor
scintigraphy (SRS) using 111In-octreotide. From the
SRS result, we found that the possible tumor location
was at the pancreas tail. This was further supported
by selective arterial calcium stimulation with venous
sampling (ASVS) (Table 2).
During the examinations for tumor location, a 
low cortisol level led us to arrange a desmopressin
(1-deamino-8D-arginine vasopressin, DDAVP) test 
to evaluate her HPA axis. Surprisingly, we found that
there was an inadequate increment in adrenocorti-
cotropic hormone (ACTH) and cortisol levels after
she took the DDAVP test (Table 3). The results of the
desmopressin test indicated adrenal insufficiency in our
patient. Therefore, in order to ameliorate her adrenal
insufficiency during her outpatient period, we pre-
scribed prednisolone 10 mg twice a day, and no serious
hypoglycemia event occurred during this period.
After identifying the tumor location, surgery was
performed. The surgeon palpated a tumor mass about
1.0 cm in diameter in the distal pancreas tail, and per-
formed a distal pancreatectomy. The pathologist re-
ported a benign insulinoma and the patient was free
from hypoglycemia after the operation. After 6 months,
we rechecked her cortisol and ACTH levels (cortisol,
16.1 µg/dL; ACTH, 29.1 pg/mL) and found that the
function of her HPA axis had normalized.
DISCUSSION
The incidence of insulinoma is approximately one case
per 250,000 patient-years [1]. Seldom is any institu-
tion worldwide faced with more than nine cases perTable 1. Patient’s biochemistry data on arrival at hospital
White cell count 7.5 × 1,000/µL
Hemoglobin 14.2 g/dL
Platelets 279 × 1,000/µL
Serum sodium 142.2 mmol/L
Serum potassium 4.3 mmol/L
Serum chloride 107 mmol/L
Aspartate aminotransferase 35 IU/L
Alanine aminotransferase 22 IU/L
Blood urea nitrogen 8.1 mg/dL
Serum creatinine 0.5 mg/dL
Ammonia 82 µg/dL
Ca++ 4.00 mg%
Table 2. Insulin level after selective arterial calcium stimulation with venous sampling
Time (s)
Baseline 20 40 60 90 120
Artery (µIU/mL)
Gastroduodenal 33.0 35.7 43.3 43.4 50.1 50.8
Superior mesenteric 25.1 29.3 22.1 32.8 29.8 32.6
Splenic 45.4 > 373.0 > 373.0 > 373.0 182.2 292.0
Proper hepatic 13.6 9.2 12.2 11.8 14.6 10.5
Table 3. Adrenocorticotropic hormone (ACTH) and
cortisol levels after 1-deamino-8D-arginine vasopressin
test
Time (min)
0 15 30 45 60
ACTH (pg/mL) < 19 < 19 < 19 < 19 < 19
Cortisol (µg/dL) 4.8 4.2 5.0 4.8 12.3
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calendar year [2–5]. There is a slight predominance 
of female cases [6]. The average age at diagnosis is
about 50. Insulinomas are usually solitary and are
located in different parts of the pancreas with an equal
frequency. They are typically benign tumors (80–90%)
with high vascularity [3,5], and often <15mm [7] at the
time of diagnosis. The development of clinical symp-
toms results from uncontrolled secretion of insulin.
Because small insulinomas are frequently undetectable
with conventional imaging methods, their diagnosis
is a great challenge to clinicians.
In this case, we chose abdominal ultrasonography
and magnetic resonance imaging as our examination
tools. However, although some reports have shown
high detection rates of pancreas islet tumors using
these methods [8,9], both of these failed in our case.
From previous literature, we know that blind distal
pancreatectomy is not an advisable procedure for
occult insulinoma [10]. Therefore, alternative methods
were necessary to locate the tumor. Insulinomas can
be stimulated to secrete insulin following calcium
infusion [11]. Selective ASVS has become an impor-
tant method for preoperative assessment. Calcium
gluconate (0.025mmol Ca++/kg) was injected into each
selectively catheterized artery and blood samples
were drawn from the right hepatic vein. According to
the findings of Doppman et al [12], more than a two-
fold rise in insulin levels within 30–120 seconds after
the injection is required to localize the insulinoma.
Sensitivities of 55–76% for detecting insulin-secreting
tumors by ASVS are described in the literature [13].
Recently, functional imaging with SRS has added a
further tool for the evaluation and detection of pan-
creatic neuroendocrine tumors (NET), based on the
characteristic expression of human somatostatin recep-
tor subtype 2 (hSSTR-2) [14]. In one study, 28% of
patients were found to have previously unknown
lesions using SRS [15]. Moreover, in some studies, SRS
may alter the stage in 24% of patients and surgical
strategy in 25% of patients. Although some insulino-
mas lack hSSTR-2, the sensitivity of SRS for detecting
them still reaches 60%. As well as being an imaging
tool, somatostatin analogues can also be used in the
treatment of insulinomas.
Hypoglycemia unawareness, which was also found
in this patient, has been largely discussed in type 1
and advanced type 2 diabetic patients. It is believed
to be related to hypoglycemia-associated autonomic
failure (HAAF) [16]. It has been proposed that elevated
cortisol is responsible for HAAF [17–19]; however,
this point of view has not been proven by subsequent
studies [20,21]. Despite the role of cortisol in HAAF,
our patient’s cortisol and ACTH levels were low when
hypoglycemic. Thus, we further proved the impair-
ment of the HPA axis by using the DDAVP test. DDAVP
is a companion regulator of corticotropin-releasing
hormone in the control of ACTH synthesis, and the
response rate is approximately 50–60% in normal
healthy subjects [22]. After confirming the possibility
of adrenal insufficiency, we prevented serious hypo-
glycemia by using prednisolone. Except for transient
impairment of the HPA response before operation,
our case showed similar findings to a case reported in
another article [23], that is, increased levels of ACTH
and cortisol after surgery. To the best of our knowl-
edge, this impairment has never been illustrated in
previous literature, and it may be related to the pro-
longed frequency of hypoglycemic episodes. However,
the underlying mechanism remains unclear.
Like many other cases, we successfully identified
the location of insulinoma using ASVS. However,
this approach is still invasive and includes some
unavoidable and troublesome complications. It is
suggested that clinicians use SRS as a preoperative
localization method since it is noninvasive and nearly
as sensitive as ASVS.
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